Here are relevant reports on : automation-workflow
-
Clinical Workflow Solutions Market by Product (Data Integration, Nurse Call Systems, Rounding Solutions, Patient Flow Management, Enterprise Reporting), End Users (Hospitals, Long-term Care, Ambulatory Care Centers) & Region - Global Forecast to 2025
The global clinical workflow solutions market growth is primed to transition from USD 9.1 billion in 2020 to USD 18.1 billion by 2025, showcasing a strong CAGR of 14.8%. Growth in this market is driven by the implementation of government initiatives supporting the adoption of HCIT solutions, advantages of clinical workflow solutions in enhancing patient care and safety, increasing patient volume due to the COVID-19 pandemic, growing adoption of EHRs and other HCIT solutions, and the rising need to curtail healthcare costs.
- Published: August 2020
- Price: $ 4950
- TOC Available:
-
Cell-free Protein Synthesis Market by Offering (Cell Extract Systems (Prokaryotic, Mammalian, Plant), Kits, Instruments, Services), Workflow, Method (Coupled TX/TL, Transcription, Translation), Application (Protein Purification) - Global Forecast to 2030
The global cell-free protein synthesis market, valued at US$203.9 million in 2024, stood at US$217.2 million in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2030, culminating in a forecasted valuation of US$308.9 million by the end of the period. Market growth is driven by increasing demand for biologics, vaccines, and personalized medicine, advancements in CFPS technologies, the need for quick prototyping of complex proteins, and the demand for commercial-scale validation of cell-free protein expression systems.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Clinical Informatics Market by Function (EHR, Clinical Workflow, PHM, Telehealth, CDSS, Diagnostic, Analytics), Therapeutic Area (Onco, Neuro, Cardio), Component (Software), Deployment (Cloud), End-user (Hospital, ASC), & Region - Global Forecast to 2030
The global clinical informatics market, valued at US$198.33 billion in 2023, stood at US$231.45 billion in 2024 and is projected to advance at a resilient CAGR of 16.0% from 2024 to 2030, culminating in a forecasted valuation of US$563.18 billion by the end of the period. Technological advancements in clinical informatics solutions, the rising need for improved data standardization, and the growing adoption of integrated solutions in clinical applications are key factors driving the market growth.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Single-molecule Real-time (SMRT) Sequencing Market by Offering (Products, Services), Workflow (Sequencing, Data Analysis), Application (Drug Discovery, Diagnostic, Agriculture), End User (Academia, Pharma, Biotech) - Forecast to 2030
The Single-molecule Real-time (SMRT) Sequencing Market, valued at US$2.83 billion in 2024, stood at US$2.92 billion in 2025 and is projected to advance at a resilient CAGR of 12.8% from 2025 to 2030, culminating in a forecasted valuation of US$5.32 billion by the end of the period. This market is expanding as long-read sequencing is used more often in rare disease diagnostics, cancer genomics, and broader precision medicine programs.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Infusion Pump Software Market by Type (DERS, Interoperability, Clinical Workflow), Indication (General Infusion, Pain & Anesthesia Management, Insulin Infusion), End User (Hospitals, Ambulatory Care Settings) - Global Forecasts to 2024
The market for infusion pump software is expected to grow USD 1,044 million by 2024, at a CAGR of 7.1% during the forecast period. The major vendors in the global infusion pump software market are BD (US), B. Braun (Germany), Baxter (US), ICU Medical (US), Terumo Medical (Japan), Fresenius Kabi (Germany), Moog (US), F. Hoffmann-La Roche (Switzerland), Ypsomed (Switzerland), Medtronic (Ireland), Smiths Medical (US), and Micrel Medical Devices (Greece).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
High-Throughput Screening (HTS) Market by Instruments (Liquid Handling, Detection, Imaging), Consumables (Reagents, Kits), Software, Services, Technology (Cell-based, High-content, Label-free), Workflow, Application, Competition - Global Forecast to 2031
The global high-throughput screening (HTS) market is projected to reach USD 45.90 billion by 2031, growing at a CAGR of 10.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Workflow Management System Market by Component (Software, Services), Software (Production, Messaging-Based, Web-Based, Suite-Based), Services, Deployment Type, Industry Verticals, and Region - Global Forecast to 2021
The workflow management system market is expected to grow from USD 3.51 Billion in 2016 to USD 9.87 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 23.0% during the forecast period. The increased focus on streamlining business processes, achieving cost efficiency through workflow management, and increased access to information is driving the workflow management system market across all regions.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (Library Prep, Target Enrichment), Sample Type (DNA), Application (Diagnostics, Drug Discovery), Method (Microfluidic, Automated), End User & Region - Global Forecast to 2028
The global NGS sample preparation market in terms of revenue was estimated to be worth $1.9 billion in 2022 and is poised to reach $4.0 billion by 2028, growing at a CAGR of 13.4% from 2022 to 2028. The market for NGS sample preparation is highly consolidated, with key players strategizing to capture the market. Prominent players in the NGS sample preparation market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), PerkinElmer Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Merck KGAA (Germany), QIAGEN (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Eurofins Scientific (Luxembourg), BGI (China), 10x Genomics (US), Sysmex Corporation (US), Psomagen (US), Zymo Research Corporation (US), Takara Bio Inc. (Japan), Novogene Co., Ltd. (China), New England Biolabs (US), Tecan Trading AG (US), Oxford Nanopore Technologies PLC (UK), PacBio (US), Medgenome (US), and Swift Biosciences Inc. (US).
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Digital Twins in Healthcare Market By Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2031
The global digital twins in healthcare market is projected to reach USD 101.19 billion by 2031, growing at a CAGR of 68.4% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
China Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Platforms, Bioinformatics), Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2031
The China Next-Generation Sequencing market, valued at USD 1.23 billion in 2025, stood at USD 1.35 billion in 2026 and is projected to advance at a resilient CAGR of 16.0% from 2026 to 2031, culminating in a forecasted valuation of USD 2.84 billion by the end of the period. Next-generation sequencing refers to advanced DNA and RNA sequencing technologies that enable rapid, high-throughput analysis of genetic material.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
